Public Health - Medetomidine and Xylazine Consumer Protection Act

This bill requires retailers selling medetomidine or xylazine products (veterinary sedatives sometimes misused in illicit drugs) to verify buyers' intended veterinary, scientific, or institutional use and confirm they are 21+ years old. Retailers must maintain records of sales, including proof of age and purpose, and face civil penalties of up to $6,500 per violation. All fines collected under this law must be deposited into Maryland's Substance Abuse Fund. The law applies to all businesses selling these products, including online platforms, and takes effect October 1, 2026.